• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Penumbra launches VR-based rehab platform

Penumbra launches VR-based rehab platform

November 15, 2022 By Sean Whooley

Penumbra REAL y-Series VR rehab system
The REAL y-Series full-body, non-tethered immersive healthcare offering for rehabilitation. [Image from Penumbra]
Penumbra (NYSE:PEN) announced today that it launched a full-body, non-tethered immersive healthcare offering for rehabilitation.

Alameda, California–based Penumbra designed its REAL y-Series product with lower and upper body sensors. They allow clinicians to track full-body movement and progress in real-time.

By expanding its virtual reality-based immersive healthcare platform, Penumbra plans to support a broad range of patients. According to a news release, these patients undergoing physical or occupational therapy could improve their physical, cognitive and mental well-being.

“Two of the largest challenges in rehabilitation are maintaining patient motivation and lack of engagement,” said Gita Barry, EVP and GM of Penumbra’s Immersive Healthcare business. “Penumbra’s latest REAL y-series is the only hands-free, sensor-based VR platform available that provides activities for both lower and upper body.”

About the Penumbra REAL-y Series

The REAL y-Series supports a wide range of conditions and levels of function, Penumbra said. As a result, it broadens utility from high-acuity to high-functioning patients. Hospitals and clinics use the system to address core and balance, cognition and functional uses. In addition, it addresses activities of daily living training and cognitive stimulation.

According to Penumbra, nearly 75% of U.S. physical therapists say patient compliance represents the biggest challenge in physical therapy today. More than half believe VR can help improve that. In addition, a majority of physical therapists (65%) expressed eagerness to use technologies like VR in their practice.

“Penumbra is advancing the latest immersive healthcare technology to help patients get back to their life with as little impairment as quickly as possible,” said Barry. “VR in healthcare can be an extraordinary resource in rehabilitation, and with our full body immersive innovation, we know we can have a tremendous impact on a broad range of patients.”

Filed Under: Business/Financial News, Featured, Health Technology, Neurological, News Well, Software / IT Tagged With: Penumbra

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy